Wells Fargo & Company Lucira Health, Inc. Transaction History

Wells Fargo & Company

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.11 - $0.83 $54 - $412	-497 Reduced 4.69%	10,109 $1,000
Q3 2022 Nov 14, 2022	SELL	$1.27 - $3.39 $5,026 - $13,417	-3,958 Reduced 27.18%	10,606 $11,000
Q2 2022 Aug 12, 2022	SELL	$1.44 - $3.94 $15,327 - $41,937	-10,644 Reduced 42.22%	14,564 $27,000
Q1 2022 May 16, 2022	SELL	$2.86 - $8.83 $157,811 - $487,230	-55,179 Reduced 68.64%	25,208 $90,000
Q4 2021 Feb 14, 2022	SELL	$4.94 - $8.94 $2,440 - $4,416	-494 Reduced 0.61%	80,387 $692,000
Q3 2021 Nov 15, 2021	SELL	$6.05 - $10.81 $1,651 - $2,951	-273 Reduced 0.34%	80,881 $614,000
Q2 2021 Aug 16, 2021	BUY	$4.56 - $11.45 $290,312 - $728,964	63,665 Added 364.03%	81,154 $538,000
Q1 2021 May 13, 2021	BUY	$11.65 - $37.0 $203,746 - $647,093	17,489 New	17,489 $211,000

Ticker LHDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,106,500
Market Cap $1.2M
Description
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.